PharmaCyte Biotech, Inc. Business Finance Contracts & Agreements
37 Contracts & Agreements
- Note Agreements (1 contract)
- Purchase Agreements (7)
- Registration Rights Agreements (3)
- Release Agreements (1)
- Share Agreements (1)
- Stock Agreements (9)
- Term Sheets (1)
- Underwriting Agreements (1)
- Warrant Agreements (13)
- Form of Registration Rights Agreement (Filed With SEC on November 16, 2023)
- Form of Convertible Note (Filed With SEC on November 16, 2023)
- Form of Purchase Agreement (Filed With SEC on November 16, 2023)
- Form of Series B Warrant (Filed With SEC on November 16, 2023)
- Form of Series A Warrant (Filed With SEC on November 16, 2023)
- Form of Registration Rights Agreement (Filed With SEC on May 11, 2023)
- Form of Purchase Agreement (Filed With SEC on May 11, 2023)
- Form of Warrant (Filed With SEC on May 11, 2023)
- Release Agreement, dated October 12, 2022, by and between PharmaCyte Biotech, Inc. and Gerald W. Crabtree (Filed With SEC on October 14, 2022)
- Securities Purchase Agreement, dated as of August 19, 2021 (Filed With SEC on August 23, 2021)
- Form of Placement Agent Common Stock Purchase Warrant (Filed With SEC on August 23, 2021)
- Form of Series A Warrant Common Stock Purchase Warrant (Filed With SEC on August 23, 2021)
- Form of Pre-Funded Common Stock Purchase Warrant (Filed With SEC on August 23, 2021)
- Form of Underwriters Warrant (Filed With SEC on August 12, 2021)
- Form of Pre-funded Warrant (Filed With SEC on August 12, 2021)
- Form of Common Warrant (Filed With SEC on August 12, 2021)
- Underwriting Agreement, dated as of August 9, 2021 (Filed With SEC on August 12, 2021)
- Share Subscription Agreement between the Company and the Investor dated January 17, 2020 (Filed With SEC on January 21, 2020)
- Fourth Amendment to Asset Purchase Agreement between the Company, S.G. Austria Pte. Ltd. and Austrianova Singapore Pte. Ltd. effective May 14, 2018 (Filed With SEC on May 15, 2018)
- Binding Term Sheet between Austrianova Singapore Pte. Ltd. andSG Austria Pte. Ltd. and PharmaCyte Biotech, Inc. (Filed With SEC on September 6, 2017)
- THIRD STOCK OPTION AGREEMENT (Filed With SEC on March 8, 2016)
- THIRD STOCK OPTION AGREEMENT (Filed With SEC on March 8, 2016)
- STOCK AND WARRANT PURCHASE AGREEMENT (Filed With SEC on January 12, 2016)
- STOCK AND WARRANT PURCHASE AGREEMENT (Filed With SEC on January 12, 2016)
- PHARMACYTE BIOTECH, INC. COMMON STOCK WARRANT AGREEMENT (Filed With SEC on January 12, 2016)
- PHARMACYTE BIOTECH, INC. COMMON STOCK WARRANT AGREEMENT (Filed With SEC on January 12, 2016)
- Second stock option agreement (Filed With SEC on March 13, 2015)
- FIRST stock option agreement (Filed With SEC on March 13, 2015)
- SECOND stock option agreement (Filed With SEC on March 13, 2015)
- FIRST stock option agreement (Filed With SEC on March 13, 2015)
- stock option agreement (Filed With SEC on October 3, 2014)
- stock option agreement (Filed With SEC on October 3, 2014)
- stock option agreement (Filed With SEC on October 3, 2014)
- ASSET PURCHASE AGREEMENT (Filed With SEC on September 25, 2014)
- PURCHASE AGREEMENT (Filed With SEC on February 19, 2014)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on February 19, 2014)
- THIRD ADDENDUM TO ASSET PURCHASE AGREEMENT By and Between Nuvilex, Inc. (NVLX) And SG Austria Private Limited (SGA) Effective As Of June 25, 2013 THIRD ADDENDUM TO ASSET PURCHASE... (Filed With SEC on July 18, 2013)